CRISPR Therapeutics
CRSP
#3565
Rank
A$5.87 B
Marketcap
A$60.61
Share price
1.43%
Change (1 day)
-28.87%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2026 (TTM): -A$0.67 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are A$23.32 Million. In 2025 the company made an earning of -A$0.87 Billion a decrease over its 2024 earnings that were of -A$0.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.67 Billion-23.11%
2025 -A$0.87 Billion59.37%
2024 -A$0.54 Billion140.62%
2023 -A$0.23 Billion-76.83%
2022 -A$0.97 Billion-271.4%
2021 A$0.56 B-209.04%
2020 -A$0.52 Billion-617.12%
2019 A$0.10 B-140.93%
2018 -A$0.25 Billion146.86%
2017 -A$99.13 Million193.19%
2016 -A$33.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-65.58%๐Ÿ‡บ๐Ÿ‡ธ USA